Cargando…
Multifunctional Nanopolymers for Blood–Brain Barrier Delivery and Inhibition of Glioblastoma Growth through EGFR/EGFRvIII, c-Myc, and PD-1
Glioblastoma (GBM) is the most prevalent primary brain cancer in the pediatric and adult population. It is known as an untreatable tumor in urgent need of new therapeutic approaches. The objective of this work was to develop multifunctional nanomedicines to treat GBM in clinical practice using combi...
Autores principales: | Patil, Rameshwar, Sun, Tao, Rashid, Mohammad Harun, Israel, Liron L., Ramesh, Arshia, Davani, Saya, Black, Keith L., Ljubimov, Alexander V., Holler, Eggehard, Ljubimova, Julia Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621221/ https://www.ncbi.nlm.nih.gov/pubmed/34835657 http://dx.doi.org/10.3390/nano11112892 |
Ejemplares similares
-
Small-Sized Co-Polymers for Targeted Delivery of Multiple Imaging and Therapeutic Agents
por: Ljubimova, Julia Y., et al.
Publicado: (2021) -
EGFRvIII: the promiscuous mutation
por: Greenall, Sameer A, et al.
Publicado: (2016) -
The natural history of EGFR and EGFRvIII in glioblastoma patients
por: Heimberger, Amy B, et al.
Publicado: (2005) -
Will EGFRvIII and neuronal-derived EGFR be targets for imipramine?
por: Li, Zesheng, et al.
Publicado: (2023) -
Development of an EGFRvIII specific recombinant antibody
por: Gupta, Puja, et al.
Publicado: (2010)